Incannex Healthcare annual r&d spending
2020
2021
2022
2023
2024
2025
Incannex Healthcare R&D Spending Growth & History (IXHL)
Incannex Healthcare's r&d spending was $10.7M for fiscal 2025.
View full Incannex Healthcare company overviewIncannex Healthcare annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $10.7M | −$2.1M | −16.55% |
| 2024 | 2024-06-30 | $12.9M | $6.6M | +104.14% |
| 2023 | 2023-06-30 | $6.3M | $937,179 | +17.45% |
| 2022 | 2022-06-30 | $5.4M | $622,307 | +13.10% |
| 2021 | 2021-06-30 | $4.7M | $2.6M | +125.03% |
| 2020 | 2020-06-30 | $2.1M | — | — |
Incannex Healthcare quarterly r&d spending
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-03-31 | $321,000 | −$2.4M | −88.26% |
| Q2 2026 | 2025-12-31 | $2.3M | $866,000 | +61.24% |
| Q1 2026 | 2025-09-30 | $1.1M | −$1.8M | −61.33% |
| Q4 2025 | 2025-06-30 | $3.7M | −$654,000 | −15.01% |
| Q3 2025 | 2025-03-31 | $2.7M | −$542,000 | −16.54% |
| Q2 2025 | 2024-12-31 | $1.4M | −$1.2M | −46.40% |
| Q1 2025 | 2024-09-30 | $2.9M | $288,000 | +11.04% |
| Q4 2024 | 2024-06-30 | $4.4M | — | — |
| Q3 2024 | 2024-03-31 | $3.3M | $1.6M | +99.94% |
| Q2 2024 | 2023-12-31 | $2.6M | $1.1M | +70.30% |
| Q1 2024 | 2023-09-30 | $2.6M | — | — |
| Q3 2023 | 2023-03-31 | $1.6M | — | — |
| Q2 2023 | 2022-12-31 | $1.5M | — | — |
Incannex Healthcare r&d spending trends
Over the last five fiscal years, Incannex Healthcare's r&d spending increased from $2.1M to $10.7M, a change of $8.6M. The latest reported quarter, Q3 2026, shows $321,000.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Incannex Healthcare source filings ↗